James Kusena

Vice President, Bioprocessing & Applications • MicrofluidX
James is the Vice President of Bioprocessing & Applications at MicrofluidX, where they are developing the Cyto Engine, a cell therapy bioprocessing and manufacturing platform.
James has experience in cell and gene therapy process development and manufacturing optimisation. His work has focused on understanding the translational requirements for robust product realisation, considering aspects such as process development, manufacturability and ultimately the clinical adoption and health economic implications. His technical experience has been focused on GMP protocol adaptation and the translational work required for GMP manufacturing of cell and gene therapies. Additionally, James has a background in Medicinal Chemistry, International Business and Health economics

Also Speaking

Lara Silverman

Founder • LIS BioConsulting

Lynn Fischer

Chief Executive Officer • TITLE21 Health Solutions

Peter Francis

Chief Medical Officer & Chief Scientific Officer • Ray Therapeutics

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.